Everything you need to win NVENTRIC — in one platform.
Who to reach, what to say, and why now on NVENTRIC — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on NVENTRIC — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
NVENTRIC has successfully closed a pre-IPO funding round of approximately $22.6 million. The round included fourteen new institutional backers, with significant participation from existing investors like Shinhan Capital. The company plans to use the funds for R&D and expanding its manufacturing infrastructure. NVENTRIC is also gearing up for a Kosdaq listing, marking a significant step in its growth trajectory.
Company Information
Company
NVENTRIC
Location
South Korea
About
NVENTRIC is a South Korean medical device company that specializes in vascular intervention. It has developed neurovascular devices, including the EVOGLIDE distal access catheter and the ULTRIVA stent retriever, which are designed for the treatment of ischemic stroke. The company has achieved significant revenue growth and is preparing for a Kosdaq listing. NVENTRIC plans to use its recent funding to enhance R&D and expand manufacturing capabilities.
South KoreaManufacturingBiotechnologyHealth CareMedicalMedical Device